The store will not work correctly when cookies are disabled.
N-(3-Aminophenyl)[3-(4-Fluorophenyl)(1H-Indazol-5-yl)]Carboxamide
ID: ALA3984032
PubChem CID: 22480211
Max Phase: Preclinical
Molecular Formula: C20H15FN4O
Molecular Weight: 346.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1cccc(NC(=O)c2ccc3[nH]nc(-c4ccc(F)cc4)c3c2)c1
Standard InChI: InChI=1S/C20H15FN4O/c21-14-7-4-12(5-8-14)19-17-10-13(6-9-18(17)24-25-19)20(26)23-16-3-1-2-15(22)11-16/h1-11H,22H2,(H,23,26)(H,24,25)
Standard InChI Key: XEQQPVSABZNGOH-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
36.1779 -1.1515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1767 -1.9710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8848 -2.3800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8830 -0.7426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5916 -1.1479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5964 -1.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3764 -2.2149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8538 -1.5498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3687 -0.8904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.6322 -2.9861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0872 -3.5965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3436 -4.3716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1447 -4.5374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6888 -3.9221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4295 -3.1493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4028 -5.3128 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.4687 -2.3790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7613 -1.9699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4680 -3.1962 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.0533 -2.3779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3466 -1.9666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6391 -2.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6380 -3.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3504 -3.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0550 -3.1913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3526 -4.4182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
13 16 1 0
2 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
24 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.37 | Molecular Weight (Monoisotopic): 346.1230 | AlogP: 4.20 | #Rotatable Bonds: 3 |
Polar Surface Area: 83.80 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.44 | CX Basic pKa: 3.90 | CX LogP: 3.74 | CX LogD: 3.73 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.49 | Np Likeness Score: -1.69 |
References
1. (2002) Indazole derivatives as JNK inhibitors and compositions and methods related thereto, |